Cognitive rehabilitation has shown efficacy in improving cognition in patients with schizophrenia but the underlying neurobiologic changes that occur during these treatments and support cognitive improvement are not well known. To examine differential changes in brain morphology in early course schizophrenia during cognitive rehabilitation vs supportive therapy. Randomized controlled trial. An outpatient research clinic at a university-based medical center that provides comprehensive care services for patients with severe mental illness. A total of 53 symptomatically stable but cognitively disabled outpatients in the early course of schizophrenia or schizoaffective disorder. A 2-year trial with annual structural magnetic resonance imaging and cognitive assessments. Cognitive enhancement therapy is an integrated approach to the remediation of cognitive impairment in schizophrenia that uses computer-assisted neurocognitive training and group-based social-cognitive exercises. Enriched supportive therapy is an illness management approach that provides psychoeducation and teaches applied coping strategies. Broad areas of frontal and temporal gray matter change were analyzed with longitudinal, voxel-based morphometry methods using mi...Continue Reading
The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study
Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy
Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study
Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?
Treating impaired cognition in schizophrenia: the case for combining cognitive-enhancing drugs with cognitive remediation
The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia
Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients
Changes in frontal-parietal activation and math skills performance following adaptive number sense training: preliminary results from a pilot study
Does practice make perfect? Results from a Chinese feasibility study of cognitive remediation in schizophrenia
Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?
L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study
Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders
A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis
Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus
Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia
Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence
Neural disruption to theory of mind predicts daily social functioning in individuals at familial high-risk for schizophrenia
Cognitive remediation for schizophrenia: current status, biological correlates and predictors of response
Association between rostral prefrontal cortical activity and functional outcome in first-episode psychosis: a longitudinal functional near-infrared spectroscopy study
Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study
Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment
Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study
Prevention and recovery in early psychosis (PREP(®)): building a public-academic partnership program in Massachusetts, United States
Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophrenia
The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?
Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms
Neural deficits in children with dyslexia ameliorated by behavioral remediation: evidence from functional MRI
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets
Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior
Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia
Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study
Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol
Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients
The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia
Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial
Cajal Bodies & Gems
Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.
Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.
Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here
Amygdala: Sensory Processes
Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.
Amygdala and Midbrain Dopamine
The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.